Group One Trading
GLMD icon

Group One Trading’s Galmed Pharmaceuticals GLMD Stock Holding History

Group One Trading’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed -$1K – 7541
2022
Q3 		$1K Hold
1
– – ﹤0.01% 7309
2022
Q2 		$1K Sell
1
-4
-80% -$5.3K ﹤0.01% 7544
2022
Q1 		$11K Hold
5
– – ﹤0.01% 7113
2021
Q4 		$13K Buy
+5
New +$18.1K ﹤0.01% 7222

Other funds holding GLMD

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $3.06B AUM 26.31% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Group One Trading's GLMD Position: Q4 2022 in Review

Group One Trading sold out of Galmed Pharmaceuticals (GLMD) in Q4 2022, closing a stake of 1 share — an estimated $1K sold.

Group One Trading first reported a position in GLMD in Q4 2021 and held it in 4 quarters. The position peaked at $13K in Q4 2021. 19 funds tracked by Wall St. Rank hold GLMD as of Q4 2022.

  • Group One Trading reported no remaining Galmed Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Group One Trading sold 1 Galmed Pharmaceuticals share in Q4 2022, an estimated $1K.
  • Group One Trading first reported a position in Galmed Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • Group One Trading's Galmed Pharmaceuticals position peaked at $13K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q4 2022.

Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.